Turkey to start administering Pfizer-BioNTech booster shots

COVID-19 booster
Credit: Unsplash/CC0 Public Domain

Turkey's health minister announced Wednesday that the country will start administering booster shots of the Pfizer-BioNTech COVID-19 vaccine to people who received their second doses at least six months ago.

In a written statement following a meeting of the country's medical advisory council, Fahrettin Koca said the booster shots would be administered as of Thursday. The program will start with people aged 60 and above, those with , as well as and other professionals considered to be at higher risk.

Previously, Turkey offered booster shots for people who were inoculated with China's Sinovac vaccine in the early stages of the country's vaccination program. In August, the government also offered two extra Pfizer-BioNTech shots for people wanting to travel to countries that have not approved the Chinese vaccine.

Turkey has administered more than 116 million doses of COVID-19 vaccines since the start of its vaccination drive in January. Koca said around 59% of the population is fully vaccinated.

"This rate has to be increased to more than 70% in order for us to achieve communal immunity," Koca said.

On Wednesday, the Health Ministry reported 29,764 new COVID-19 cases in the past 24 hours and 246 deaths.

More than 68,700 people have died in Turkey since the start of the outbreak.

© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Citation: Turkey to start administering Pfizer-BioNTech booster shots (2021, November 3) retrieved 11 May 2024 from https://medicalxpress.com/news/2021-11-turkey-pfizer-biontech-booster-shots.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Australia approves vaccine booster shots for adults

3 shares

Feedback to editors